Rebuttal Letter to the Editor Kloosterboer et al., Therapeutic Drug Monitoring 2018;40: 344-350

2018-12-01

Therapeutic Drug Monitoring , Volume 40 - Issue 6 p. 762

Additional Metadata
Persistent URL	doi.org/10.1097/FTD.0000000000000560, hdl.handle.net/1765/112347
Journal	Therapeutic Drug Monitoring
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kloosterboer, S., de Winter, B., Bahmany, S., Al-Hassany, L. (Linda), Dekker, A. (Annet), Dieleman, G., … Koch, B. (2018). Rebuttal Letter to the Editor Kloosterboer et al., Therapeutic Drug Monitoring 2018;40: 344-350. Therapeutic Drug Monitoring, 40(6). doi:10.1097/FTD.0000000000000560

Publication